Plain-English translation of NCT07626450 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether hyperbaric oxygen therapy — treatment in a pressurized chamber with extra oxygen — can help improve recovery after you've received emergency clot removal surgery for a major stroke. Half of participants will receive standard stroke care plus the oxygen therapy, while the other half will receive standard care alone. Researchers will measure how well people recover 90 days after treatment.
After emergency clot removal, stroke patients still face significant disability and brain damage. This medication aims to reduce that damage by increasing oxygen delivery to the brain during the critical healing period.
You likely qualify if…
You likely don't qualify if…
After your emergency clot removal surgery, you will be randomly assigned to one of two groups. One group will receive standard medical care plus sessions in a hyperbaric oxygen chamber (a pressurized room with extra oxygen); the other group will receive standard care only. You will have follow-up visits and assessments at 90 days after treatment to measure your recovery and level of independence with daily activities.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
China
Sponsor
Beijing Tiantan Hospital
Enrollment target
~420 participants
Started
June 2026
Primary completion
September 2027
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ning Ma, MD
Beijing Tiantan Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.